MM&M

Abbott sales dip in Q3 due to COVID testing sales declines, infant formula manufacturing stoppage

Abbott’s sales in Q3 totaled $10.4 billion, marking a decrease of 4.7%, though the company once again raised its full-year guidance. The dip in the company’s sales were due in part to declines in ...
MM&M

Abbott sales 18% fall due to anticipation of COVID testing sales declines

Abbott Laboratories’ reported sales fell 18.1% in Q1 due to what the company called an “anticipated decline” in COVID-19 testing-related sales compared to 2022. Abbott’s Diagnostics segment ...
Forbes

This Startup Is On A Mission To Redefine Accessible Pregnancy Testing

Saliva is the new medium for testing and non-invasive, simple, accessible diagnostics. Israeli startup Salignostics is leading the search for saliva-based testing solutions, allowing for accurate ...
Forbes

Abbott Labs Reports $1 Billion Profit Despite Falling Covid Test Sales

The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada. (Photo by Patrick T. FALLON / AFP) (Photo by ...